Recent advances in developing targeted protein degraders

Eur J Med Chem. 2024 Dec 27:284:117212. doi: 10.1016/j.ejmech.2024.117212. Online ahead of print.

Abstract

Targeted protein degradation (TPD) represents a promising therapeutic approach, encompassing several innovative strategies, including but not limited to proteolysis targeting chimeras (PROTACs), molecular glues, hydrophobic tag tethering degraders (HyTTD), and lysosome-targeted chimeras (LYTACs). Central to TPD are small molecule ligands, which play a critical role in mediating the degradation of target proteins. This review summarizes the current landscape of small molecule ligands for TPD molecules. These small molecule ligands can utilize the proteasome, lysosome, autophagy, or hydrophobic-tagging system to achieve the degradation of target proteins. The article mainly focuses on introducing their design principles, application advantages, and potential limitations. A brief discussion on the development prospects and future directions of TPD technology was also provided.

Keywords: HyTTD; LYTACs; Molecular glues; PROTACs; Small molecule ligands; Targeted protein degradation.

Publication types

  • Review